Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison E John

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 30, 2013
Preclinical SPECT/CT imaging of αvβ6 integrins for molecular stratification of idiopathic pulmonary fibrosisAlison E John, Jeni C Luckett, Amanda L Tatler, et al.
Plos One|August 6, 2016
Amplification of TGFβ Induced ITGB6 Gene Transcription May Promote Pulmonary FibrosisAmanda L Tatler, Amanda T Goodwin, Olumide Gbolahan, et al.
The International Journal of Biochemistry & Cell Biology|December 27, 2019
Loss of ELK1 has differential effects on age-dependent organ fibrosisJennifer T Cairns, Anthony Habgood, Rochelle C Edwards-Pritchard, et al.
The Journal of Biological Chemistry|February 11, 2016
Reduced Ets Domain-containing Protein Elk1 Promotes Pulmonary Fibrosis via Increased Integrin αvβ6 ExpressionAmanda L Tatler, Anthony Habgood, Joanne Porte, et al.
The European Respiratory Journal|January 8, 2022
Lysyl oxidase like 2 is increased in asthma and contributes to asthmatic airway remodellingJopeth Ramis, Robert Middlewick, Francesco Pappalardo, et al.
The Journal of Biological Chemistry|April 19, 2024
Defining the mechanism of galectin-3-mediated TGF-β1 activation and its role in lung fibrosisJessica F Calver, Nimesh R Parmar, Gemma Harris, et al.
Thorax|June 19, 2025
Basement membrane repair response biomarker PRO-C4 predicts progression in idiopathic pulmonary fibrosis: analysis of the PFBIO and PROFILE cohortsJannie M B Sand, Peder Frederiksen, Alison E John, et al.
European Journal of Pharmacology|November 11, 2021
Pharmacological characterisation of GSK3335103, an oral αvβ6 integrin small molecule RGD-mimetic inhibitor for the treatment of fibrotic diseaseAlex L Wilkinson, Alison E John, John W Barrett, et al.
Nature Communications|September 17, 2020
Translational pharmacology of an inhaled small molecule αvβ6 integrin inhibitor for idiopathic pulmonary fibrosisAlison E John, Rebecca H Graves, K Tao Pun, et al.
The Lancet. Respiratory Medicine|October 26, 2017
Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association studyRichard J Allen, Joanne Porte, Rebecca Braybrooke, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 30, 2013
Preclinical SPECT/CT imaging of αvβ6 integrins for molecular stratification of idiopathic pulmonary fibrosisAlison E John, Jeni C Luckett, Amanda L Tatler, et al.
Plos One|August 6, 2016
Amplification of TGFβ Induced ITGB6 Gene Transcription May Promote Pulmonary FibrosisAmanda L Tatler, Amanda T Goodwin, Olumide Gbolahan, et al.
The International Journal of Biochemistry & Cell Biology|December 27, 2019
Loss of ELK1 has differential effects on age-dependent organ fibrosisJennifer T Cairns, Anthony Habgood, Rochelle C Edwards-Pritchard, et al.
The Journal of Biological Chemistry|February 11, 2016
Reduced Ets Domain-containing Protein Elk1 Promotes Pulmonary Fibrosis via Increased Integrin αvβ6 ExpressionAmanda L Tatler, Anthony Habgood, Joanne Porte, et al.
The European Respiratory Journal|January 8, 2022
Lysyl oxidase like 2 is increased in asthma and contributes to asthmatic airway remodellingJopeth Ramis, Robert Middlewick, Francesco Pappalardo, et al.
The Journal of Biological Chemistry|April 19, 2024
Defining the mechanism of galectin-3-mediated TGF-β1 activation and its role in lung fibrosisJessica F Calver, Nimesh R Parmar, Gemma Harris, et al.
Thorax|June 19, 2025
Basement membrane repair response biomarker PRO-C4 predicts progression in idiopathic pulmonary fibrosis: analysis of the PFBIO and PROFILE cohortsJannie M B Sand, Peder Frederiksen, Alison E John, et al.
European Journal of Pharmacology|November 11, 2021
Pharmacological characterisation of GSK3335103, an oral αvβ6 integrin small molecule RGD-mimetic inhibitor for the treatment of fibrotic diseaseAlex L Wilkinson, Alison E John, John W Barrett, et al.
Nature Communications|September 17, 2020
Translational pharmacology of an inhaled small molecule αvβ6 integrin inhibitor for idiopathic pulmonary fibrosisAlison E John, Rebecca H Graves, K Tao Pun, et al.
The Lancet. Respiratory Medicine|October 26, 2017
Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association studyRichard J Allen, Joanne Porte, Rebecca Braybrooke, et al.
Pageof 4